Company overview
Zhejiang Haisen Pharmaceutical Co., Ltd.
USCC
913307837045812886
Id2
330783000011022
English Name
Zhejiang Haisen Pharmaceutical Co., Ltd.
Former names
东阳市化学制药有限公司, 浙江海森药业有限公司, 东阳市海森药业有限公司
Chinese Name
浙江海森药业股份有限公司
Entity type
Joint Stock Company (Non-Listed, Natural Person Invested or Controlled)
Authorized capital
¥5,100
18858932039@139.com
Phone
+8657986768686
Representative
王式跃 (Wang Shi Yue)
Establishment date
18 February 1998
Country
China
Primary goods traded
- 57.8% — Sugars, chemically pure, other than sucrose, lactose, maltose, glucose and fructose (294000)
- 27.8% — Heterocyclic compounds (293311)
- 11.4% — Organic compounds (294200)
- 3.0% — Heterocyclic compounds (293319)
Main Trading Partners
| Partner | Type | Total Value | Percentage |
|---|---|---|---|
| PT Dexa Medica | buyer | $3,084,235 | 33.13% |
| PT Bina San Prima | buyer | $2,375,760 | 25.52% |
| PT Wolong Soko Indonesia | buyer | $468,454 | 5.03% |
| PT Ferron Par Pharmaceuticals | buyer | $446,838 | 4.80% |
| PT Satya Samitra Niagatama | buyer | $407,000 | 4.37% |
| PT Sanbe Farma | buyer | $405,400 | 4.35% |
| PT Global Chemindo Megatrading | buyer | $324,626 | 3.49% |
| Wockhardt Limited | buyer | $98,000 | 1.05% |
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Loading chart...
Trade Data
| Data Source | HS Code | Description | Buyer | Buyer Country | Seller | Seller Country | ||
|---|---|---|---|---|---|---|---|---|
| 4 December 2020 | PK | 29400000 | Pharmaceutical Allopathic Raw Materialsucralfate Micronized | Highnoon Laboratories Limited | PK | Zhejiang Haisen Pharmaceutical Company Limited | ID | $200,000.00 |
| 5 August 2024 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | $159,600.00 | |
| 12 December 2023 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) Coa Terlampir | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | $137,160.00 | |
| 16 May 2023 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) Coa Terlampir | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | $135,000.00 | |
| 18 July 2018 | ID | 29331100 | Metamizole Sodium (Methampyron) (Bahan Baku Obat Untuk Manusia) Coa Terlampir | PT Bina San Prima | ID | Zhejiang Haisen Pharmaceutical Company Limited | CN | $131,600.00 |
| 10 October 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,850.00 | |
| 8 August 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,650.00 | |
| 12 September 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,610.00 | |
| 6 July 2023 | ID | 29400000 | Sucralfate Usp Kd Baik Baru | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,600.00 | |
| 12 December 2023 | ID | 29400000 | Sucralfate Usp (Micronized) | PT Dexa Medical | ID | Zhejiang Haisen Pharmaceutical Company Limited | $127,400.00 |
0 of 20 row(s) selected.